Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer
Main Authors: | Granata, A, Nicoletti, R, Tinaglia, V, De Cecco, L, Pisanu, M E, Ricci, A, Podo, F, Canevari, S, Iorio, E, Bagnoli, M, Mezzanzanica, D |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899765/ |
Similar Items
-
Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma
by: Granata, Anna, et al.
Published: (2015) -
Choline Metabolism Alteration: A Focus on Ovarian Cancer
by: Bagnoli, Marina, et al.
Published: (2016) -
In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer
by: Canese, Rossella, et al.
Published: (2016) -
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy
by: Pisanu, M E, et al.
Published: (2014) -
Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism
by: Penet, Marie-France, et al.
Published: (2016)